]>
IRCT20130812014333N101 IRCT 2018-09-18 Kermanshah University of Medical Sciences Study the efficacy of risperidone in the treatment of persistent psychosis induced by methamphetamine Study the efficacy of risperidone compared to placebo plus Electroconvulsive therapy in the treatment of persistent psychosis induced by methamphetamine in patients referred to Farabi hospital of Kermanshah 2018-09-18 anticipated 12 Complete https://irct.ir/trial/33672 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomly by coin toss, Blinding description: In this study, patients and researcher will be blinded to the study groups, the dosage of the drug and the manufacturer of the drug. 2-3 Amphtamine induced psychotic disorder. Intervention 1: The first intervention group will receive 4 mg Risperidone (in two divided doses) daily for 4 weeks with a two-way frontotemporal ECT. Intervention 2: The second intervention group will receive placebo and ECT as two-way frontotemporal twice a week for 4 weeks (Risperidone and placebo will be provided in 30pcs-drug containers). Yes - There is a plan to make this available What will be shared: The main outcomes of the study will be shared. When: 4 months To whom: If requested, results will be made available to other academic researchers Conditions: Collected data is confidential and will not be shared with anyone else Where to obtain: To receive the documentation, email send for update manager How to obtain: In a 15-day period, the documents will be sent e-mail Comments:
public Abdoll Reza Darki
Farabi Hospital Isar Square, Dolatabad Blvd,
Kermanshah Iran (Islamic Republic of) 6715847141 +98 83 3826 1046 darki121@yahoo.com Kermanshah University of Medical Sciences scientific Dr. Vahid Farnia
Farabi Hospital Isar Square, Dolatabad Blvd,
Kermanshah Iran (Islamic Republic of) 6715847141 +98 83 3826 1046 vahidfarnia@yahoo.com Kermanshah University of Medical Sciences Iran (Islamic Republic of) The presence of psychosis due to methamphetamine consumption despite discontinuation of methamphetamine for one month No history of previous psychiatric disorders such as schizophrenia and ..... No medical diseases that have psychosis symptoms such as brain tumors and ... no limit no limit Both No persistent psychosis associated with methamphetamine abuse. The presence of recent cardiovascular disease based on the patient's history or cardiologist's opinion Sensitivity or side effects during treatment with risperidone. History or presence of primary psychosis F 15 Mental and behavioural disorders due to use of other stimulants, including caffeine Treatment - Drugs Placebo The first intervention group will receive 4 mg Risperidone (in two divided doses) daily for 4 weeks with a two-way frontotemporal ECT. The second intervention group will receive placebo and ECT as two-way frontotemporal twice a week for 4 weeks (Risperidone and placebo will be provided in 30pcs-drug containers) Severity of psychotic symptoms. Timepoint: At the beginning of the study, the second week and at the end of the study (4 weeks after the start of the study). Method of measurement: Based on the Positive and Negative Symptoms Scale (PANSS). Kermanshah University of Medical Sciences Approved 2017-10-26 Ethics committee of Kermanshah University of Medical Sciences Vice Chancellor for Research Affairs, Kermanshah University of Medical Sciences, Building No.2, Shahid Beheshti Kermanshah Kermanshah Iran (Islamic Republic of)